Effect of Imatinib on Bone Marrow Morphology and Angiogenesis in Chronic Myeloid Leukemia.

Conclusion: Imatinib therapy in CML not only decreases marrow cellularity, but also helps towards normalization of bone marrow microenvironment by reducing fibrosis and angiogenesis.
PMID: 30713559 [PubMed]

Source: Advances in Hematology - February 5, 2019 Category: Hematology Tags: Adv Hematol Source Type: research